L3VLUP
ProSign in

EYE · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

EYEJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • EYE
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterEYEJNJ
Q3 20206 holders, $358m30 holders, $26.2bn
Q4 20204 holders, $378m32 holders, $26.6bn
Q1 20215 holders, $381m31 holders, $25.3bn
Q2 20215 holders, $517m37 holders, $25.6bn
Q3 20215 holders, $575m40 holders, $24.1bn
Q4 20215 holders, $523m33 holders, $25.2bn
Q1 20226 holders, $632m35 holders, $28.2bn
Q2 20224 holders, $290m33 holders, $26.9bn
Q3 20224 holders, $333m36 holders, $25.4bn
Q4 20225 holders, $380m35 holders, $27.6bn
Q1 20234 holders, $25m42 holders, $24.5bn
Q2 20234 holders, $84m38 holders, $25.0bn
Q3 20235 holders, $59m37 holders, $18.9bn
Q4 20234 holders, $55m31 holders, $19.0bn
Q1 20247 holders, $75m32 holders, $19.7bn
Q2 20244 holders, $38m35 holders, $20.4bn
Q3 20245 holders, $44m28 holders, $22.3bn
Q4 20243 holders, $9.2m37 holders, $20.4bn
Q1 20256 holders, $79m32 holders, $20.5bn
Q2 20258 holders, $161m31 holders, $18.4bn
Q3 20257 holders, $300m32 holders, $23.7bn
Q4 20256 holders, $280m29 holders, $27.8bn
Q1 20266 holders, $263m34 holders, $35.6bn
Q2 20265 holders, $224m33 holders, $39.1bn
EYE

National Vision HLDGS Inc

Holders
8
Reported value
$161m
Buyers
6
Sellers
3

Breadth +3 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
31
Reported value
$18.4bn
Buyers
15
Sellers
16

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only EYE (3)

ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Glenview Capital Management LLC

Only JNJ (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, Wellington Management Group LLP, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →